U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
The FDA has approved a new medication for people with Alzheimer’s disease. Eli Lilly’s Kisunla (donanemab) is a once-monthly ...
The Food and Drug Administration granted approval Tuesday to a closely watched Alzheimer’s drug, concluding that the benefits ...
The Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a study suggested that it ...
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second ...
The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly’s LLY.N donanemab for patients with early ...
It’s a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial ...
FDA-approved drug brings hope to Americans living with Alzheimer's Read full article ... Kisunla is the second approved drug ...
The FDA approved Eli Lilly's Alzheimer's drug, expanding treatment options for the disease in the US. It will be sold under ...
The FDA approved Eli Lilly's drug Kisunla to treat early-stage Alzheimer's disease. Kisunla is only the second drug approved ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
SARASOTA, Fla. (SNN) — The Food and Drug Administration has approved a new Alzheimer’s drug from Eli Lilly. According to Eli ...